Skip to main content Skip to footer
American Family Children's Hospital
SHARE TEXT
 
Ticiana A. Leal, MD close
Uwwa5VbBNVo
Ticiana A. Leal, MD
 

New Patients

Need help selecting a primary care doctor? Contact the Welcome Center for personal assistance.

For Referring Physicians

How to refer a patient

Ticiana A. Leal, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Leal earned her medical degree from the Federal University of Ceara, Brazil, and completed her residency at University of Chicago Hospitals. She completed her fellowship at University of Wisconsin Hospital and Clinics and the University of Illinois. Dr. Leal is board certified in internal medicine, geriatrics, medical oncology and palliative care medicine. 

Specialties

Medical Oncology

Lung Cancer

Clinics

UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map

Hospital Affiliation(s)

Veterans Hospital - Wm. S. Middleton Memorial
Richland Hospital

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Hospice and Palliative Medicine
Medical Oncology
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
University of Illinois, Chicago, IL
Residency University of Chicago Hospitals, Chicago, IL
Medical School Federal University of Ceara, Fortaleza, Brazil

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Li C Yu J Schehr J Berry SM Leal TA Lang JM Beebe DJ Exclusive Liquid Repellency: An Open Multi-Liquid-Phase Technology for Rare Cell Culture and Single-Cell Processing. ACS Appl Mater Interfaces . 2018 May 23;10(20):17065-17070
[PubMed ID: 29738227]
Horn L Infante JR Reckamp KL Blumenschein GR Leal TA Waqar SN Gitlitz BJ Sanborn RE Whisenant JG Du L Neal JW Gockerman JP Dukart G Harrow K Liang C Gibbons JJ Holzhausen A Lovly CM Wakelee HA Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study. Clin Cancer Res . 2018 Mar 21;
[PubMed ID: 29563138]
Leal TA Ramalingam SS Immunotherapy in previously treated non-small cell lung cancer (NSCLC). J Thorac Dis . 2018 Feb;10(Suppl 3):S422-S432
[PubMed ID: 29593888]
Leal T Wakelee H Infante J Blumenschein G Reckamp K Carter C Waqar S Gockerman J Lovly C Dukart G Harrow K Liang C Gibbons J Horn L P1.44 (also presented as PD2.02): Phase I/II Trial of X-396, A Novel ALK Inhibitor, in Patients With ALK+ NSCLC: Track: Advanced NSCLC. J Thorac Oncol . 2016 Oct;11(10S):S209-S210
[PubMed ID: 27676529]
Leal T Wakelee H Infante J Blumenschein G Reckamp K Carter C Waqar S Gockerman J Lovly C Dukart G Harrow K Liang C Gibbons J Horn L PD2.02 (also presented as P1.44): Phase I/II Trial of X-396, a Novel ALK Inhibitor, in Patients With ALK+ NSCLC. J Thorac Oncol . 2016 Oct;11(10S):S176-S177
[PubMed ID: 27676483]
Schehr JL Schultz ZD Warrick JW Guckenberger DJ Pezzi HM Sperger JM Heninger E Saeed A Leal T Mattox K Traynor AM Campbell TC Berry SM Beebe DJ Lang JM High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1. PLoS One . 2016;11(7):e0159397
[PubMed ID: 27459545]
Halverson JL Martinez-Donate AP Palta M Leal T Lubner S Walsh MC Schaaf Strickland J Smith PD Trentham-Dietz A Health Literacy and Health-Related Quality of Life Among a Population-Based Sample of Cancer Patients. J Health Commun . 2015;20(11):1320-9
[PubMed ID: 26161549]
Leal TB Remick SC Takimoto CH Ramanathan RK Davies A Egorin MJ Hamilton A LoRusso PA Shibata S Lenz HJ Mier J Sarantopoulos J Mani S Wright JJ Ivy SP Neuwirth R von Moltke L Venkatakrishnan K Mulkerin D Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study. Cancer Chemother Pharmacol . 2011 Dec;68(6):1439-47
[PubMed ID: 21479634]
Leal T Chang JE Mehta M Robins HI Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment. Curr Cancer Ther Rev . 2011 Nov;7(4):319-327
[PubMed ID: 23251128]
Loconte NK Williamson A Gayle A Weiss J Leal T Cetnar J Mohammed T Tevaarwerk A Jones N Increasing Disparity in Colorectal Cancer Incidence and Mortality Among African Americans and Whites: A State's Experience. J Gastrointest Oncol . 2011;2(2):85-92
[PubMed ID: 21712962]
Chao BH Lepeak L Leal T Robins HI Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes. Thrombosis . 2011;2011:530183
[PubMed ID: 22084664]
Leal T Tevaarwerk A Love R Stewart J Binkley N Eickhoff J Parrot B Mulkerin D Randomized trial of adjuvant zoledronic acid in postmenopausal women with high-risk breast cancer. Clin Breast Cancer . 2010 Dec 1;10(6):471-6
[PubMed ID: 21147691]
Leal T Robins HI Bevacizumab induced reversible thrombocytopenia in a patient with recurrent high-grade glioma: a case report. Cancer Chemother Pharmacol . 2010 Jan;65(2):399-401
[PubMed ID: 19756604]